Mutakamela Insurance Company (TADAWUL:8040)

Ligand Pharmaceuticals Revenue

Mutakamela Insurance Company had revenue of 137.64M SAR in the quarter ending June 30, 2025, a decrease of -14.40%. This brings the company's revenue in the last twelve months to 578.37M, down -12.47% year-over-year. In the year 2024, Mutakamela Insurance Company had annual revenue of 642.17M with 3.66% growth.

• Revenue (ttm): 578.37M
• Revenue Growth: -12.47%
• P/S Ratio: 1.51
• Revenue / Employee: 1.16M
• Employees: 498
• Market Cap: 871.65M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	642.17M	22.67M	3.66%
Dec 31, 2023	619.50M	165.98M	36.60%
Dec 31, 2022	453.52M	15.76M	3.60%
Dec 31, 2021	437.76M	-105.44M	-19.41%
Dec 31, 2020	543.20M	-162.53M	-23.03%